{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:59:15Z","timestamp":1790265555466,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013047","name":"Cultivating Plan Program for the Leader in Science and Technology of Yunnan Province","doi-asserted-by":"publisher","award":["2017Y0061"],"award-info":[{"award-number":["2017Y0061"]}],"id":[{"id":"10.13039\/501100013047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008137","name":"Ministry of Natural Resources","doi-asserted-by":"publisher","award":["2018020"],"award-info":[{"award-number":["2018020"]}],"id":[{"id":"10.13039\/100008137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31401210"],"award-info":[{"award-number":["31401210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31571455"],"award-info":[{"award-number":["31571455"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600483"],"award-info":[{"award-number":["81600483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.intimp.2019.105816","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T12:21:56Z","timestamp":1566217316000},"page":"105816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPAR\u03b3-dependent manner"],"prefix":"10.1016","volume":"75","author":[{"given":"Jianlin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianli","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junde","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangjuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2019.105816_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin. Liver Dis."},{"issue":"8","key":"10.1016\/j.intimp.2019.105816_bb0010","first-page":"1075","article-title":"Liver fibrosis: a dynamic and potentially reversible process","volume":"25","author":"Povero","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.intimp.2019.105816_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2019.105816_bb0020","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1476-5926-2-S1-S7","article-title":"PPAR gamma and hepatic stellate cells","volume":"3","author":"Hazra","year":"2004","journal-title":"Comp. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105816_bb0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1499-3872(11)60009-X","article-title":"Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"6","key":"10.1016\/j.intimp.2019.105816_bb0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000485837","article-title":"n\u22123 polyunsaturated fatty acids and cardiovascular disease: principles, practices, pitfalls, and promises - a contemporary review","volume":"26","author":"Kones","year":"2017","journal-title":"Med. Princ. Pract."},{"issue":"3","key":"10.1016\/j.intimp.2019.105816_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5114\/fn.2013.37708","article-title":"The neuroprotective effect of long-term n\u22123 polyunsaturated fatty acids supplementation in the cerebral cortex and hippocampus of aging rats","volume":"51","author":"Firlag","year":"2013","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.intimp.2019.105816_bb0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.intimp.2017.09.013","article-title":"Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats","volume":"53","author":"He","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2019.105816_bb0045","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.intimp.2019.105816_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2840-7-6","article-title":"Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?","volume":"7","author":"Gani","year":"2008","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105816_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/iub.1478","article-title":"Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K\/Akt pathway","volume":"68","author":"Chen","year":"2016","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.intimp.2019.105816_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.intimp.2019.105816_bb0065","first-page":"349","volume":"37","author":"Carpino","year":"2005","journal-title":"Stud. Liver"},{"issue":"4","key":"10.1016\/j.intimp.2019.105816_bb0070","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3892\/mmr.2016.5673","article-title":"Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2019.105816_bb0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-beta signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"issue":"3","key":"10.1016\/j.intimp.2019.105816_bb0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"Czochra","year":"2006","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2019.105816_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.intimp.2019.105816_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jcp.1041360323","article-title":"Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture","volume":"136","author":"Davis","year":"1988","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2019.105816_bb0095","doi-asserted-by":"crossref","first-page":"495156","DOI":"10.1155\/2013\/495156","article-title":"The effect of inflammatory cytokines in alcoholic liver disease","volume":"2013","author":"Kawaratani","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.intimp.2019.105816_bb0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2249.1994.tb07031.x","article-title":"IL-6 induces hepatic inflammation and collagen synthesis in vivo","volume":"95","author":"Choi","year":"1994","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105816_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.intimp.2019.105816_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.plefa.2009.05.004","article-title":"Toxicology and safety of DHA","volume":"81","author":"Lien","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"2","key":"10.1016\/j.intimp.2019.105816_bb0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-012-2489-5","article-title":"Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats","volume":"58","author":"Chen","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2019.105816_bb0120","series-title":"Fish and Fish Oil in Health and Disease Prevention","first-page":"75","article-title":"Fish oils in human nutrition: history and current status","author":"Rice","year":"2016"},{"issue":"2","key":"10.1016\/j.intimp.2019.105816_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"4","key":"10.1016\/j.intimp.2019.105816_bb0130","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/j.gastro.2011.02.044","article-title":"Nuclear receptors as new perspective for the management of liver diseases","volume":"140","author":"Trauner","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2019.105816_bb0135","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/thno.22237","article-title":"Ligand activation of PPARgamma by ligustrazine suppresses pericyte functions of hepatic stellate cells via SMRT-mediated transrepression of HIF-1alpha","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2019.105816_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fnmol.2018.00331","article-title":"Peroxisome proliferator activated receptor agonists modulate transposable element expression in brain and liver","volume":"11","author":"Ferguson","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.intimp.2019.105816_bb0145","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.HYP.36.5.851","article-title":"Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase","volume":"36","author":"Diep","year":"2000","journal-title":"Hypertension"},{"issue":"21","key":"10.1016\/j.intimp.2019.105816_bb0150","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1021\/bi0159581","article-title":"Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662","volume":"41","author":"Leesnitzer","year":"2002","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.intimp.2019.105816_bb0155","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/mol.109.056911","article-title":"Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel","volume":"76","author":"Pavlov","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105816_bb0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/auto.6.1.10437","article-title":"Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling","volume":"6","author":"Yan","year":"2010","journal-title":"Autophagy"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2019.105816_bb0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11010-011-0978-z","article-title":"Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway","volume":"358","author":"Dong","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.intimp.2019.105816_bb0170","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.ajpath.2014.01.026","article-title":"Inhibitory effects of PPARgamma ligands on TGF-beta1-induced corneal myofibroblast transformation","volume":"184","author":"Jeon","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2019.105816_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcp.2015.11.026","article-title":"Pioglitazone, a PPARgamma agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR\/p70S6K and ERK signaling","volume":"101","author":"Osman","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105816_bb0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jnutbio.2010.11.022","article-title":"Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats","volume":"23","author":"Chen","year":"2012","journal-title":"J. Nutr. Biochem."},{"issue":"10","key":"10.1016\/j.intimp.2019.105816_bb0185","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1194\/jlr.M061275","article-title":"Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr\u2212\/\u2212 mice by targeting the TGFbeta-Smad3 pathway","volume":"56","author":"Lytle","year":"2015","journal-title":"J. Lipid Res."},{"issue":"14","key":"10.1016\/j.intimp.2019.105816_bb0190","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1096\/fj.06-6250fje","article-title":"Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA","volume":"20","author":"Gonzalez-Periz","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2019.105816_bb0195","doi-asserted-by":"crossref","first-page":"30029","DOI":"10.1038\/srep30029","article-title":"Omega-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP\/TAZ degradation","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2019.105816_bb0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"30","key":"10.1016\/j.intimp.2019.105816_bb0205","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.3748\/wjg.v11.i30.4735","article-title":"Effect of ligand of peroxisome proliferator-activated receptor gamma on the biological characters of hepatic stellate cells","volume":"11","author":"Guo","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105816_bb0210","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s10620-019-5462-8","article-title":"Rosiglitazone inhibits activation of hepatic stellate cells via up-regulating micro-RNA-124-3p to alleviate hepatic fibrosis","volume":"64","author":"Zhi","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2019.105816_bb0215","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/jhep.2001.24024","article-title":"Involvement of p21(WAF1\/Cip1), p27 (Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines","volume":"33","author":"Koga","year":"2001","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.intimp.2019.105816_bb0220","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1182\/blood.V124.21.5211.5211","article-title":"PPAR-\u03b3 agonists induce growth arrest of kit\/AML1-ETO leukemia cells acting on diverse pathways","volume":"124","author":"Agosti","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2019.105816_bb0225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/12013","article-title":"SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27","volume":"1","author":"Carrano","year":"1999","journal-title":"Nat. Cell Biol."},{"issue":"24","key":"10.1016\/j.intimp.2019.105816_bb0230","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1074\/jbc.274.24.17088","article-title":"Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21 (Waf1\/Cip1), during adipogenesis","volume":"274","author":"Morrison","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2019.105816_bb0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/0003489418787833","article-title":"PPARgamma-mediated p21 induction in aerodigestive preneoplastic cell lines","volume":"127","author":"Miller","year":"2018","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105816_bb0240","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1158\/1078-0432.CCR-03-0985","article-title":"Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells","volume":"10","author":"Han","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"6662","key":"10.1016\/j.intimp.2019.105816_bb0245","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"issue":"7059","key":"10.1016\/j.intimp.2019.105816_bb0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.intimp.2019.105816_bb0255","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1182\/blood-2006-07-038026","article-title":"Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C\/EBP","volume":"110","author":"Wang","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.intimp.2019.105816_bb0260","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n\u22123 and n\u22126 polyunsaturated fatty acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2019.105816_bb0265","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gutjnl-2012-303179","article-title":"Molecular interplay between Delta5\/Delta6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis","volume":"63","author":"Lopez-Vicario","year":"2014","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2019.105816_bb0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919311531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919311531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:46:12Z","timestamp":1762551972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919311531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":54,"alternative-id":["S1567576919311531"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105816","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736479160.793564459","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPAR\u03b3-dependent manner","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105816"}}